Viridian Therapeutics, Inc.\DE (VRDN) Insider Trading Disclosures
Viridian Therapeutics, Inc.\DE (VRDN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VRDN
CIK: 1590750
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerAndrew Malachowski
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-20 | 2026-08-19 | 4 | 0001193125-26-359636 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-20 | — | SCHEDULE 13G Filing | 0000919574-26-005637 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001959173-26-006222 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 | 0001193125-26-355735 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097208 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001907884-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000080255-26-000556 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003486 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000558 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001590750-26-000018 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336691 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-294561 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-294560 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-294556 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-294552 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-294547 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-294546 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-26 | 8-K | 0001193125-26-286273 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-26 | — | SCHEDULE 13G Filing | 0001104659-26-078245 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-02 | 8-K | 0001193125-26-254560 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-27 | 8-K | 0001193125-26-245186 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-24 | 8-K | 0001193125-26-239246 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001104659-26-062332 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | OWNERSHIP DOCUMENT | 0001104659-26-060294 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-13 | — | SCHEDULE 13D/A Filing | 0001104659-26-060292 | View SEC Doc Filr Page |